Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemiaLaurens F Reeskamp John J. P Kastelein; Patrick M Moriarty; P. Barton Duell; Alberico L Catapano; Raul Dias dos Santos Filho; Christie M BallantyneAtherosclerosis v. 280, p. 109-117, 2019Clare 2019Acesso online. A biblioteca também possui exemplares impressos. |
2 |
Material Type: Artigo
|
![]() |
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities studyHoogeveen, Ron C. ; Morrison, Alanna ; Boerwinkle, Eric ; Miles, J. Shawn ; Rhodes, Charles E. ; Sharrett, A. Richey ; Ballantyne, Christie M.Atherosclerosis, 2005-12, Vol.183 (2), p.301-307 [Periódico revisado por pares]Amsterdam: Elsevier Ireland LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Comparative effects of cholesteryl ester transfer protein inhibition, statin and ezetimibe therapy on atherogenic and protective lipid factors: The accentuate trialNicholls, S ; Ray, K ; Ballantyne, C ; Beacham, L ; Miller, D ; Ruotolo, G ; Riesmeyer, JAtherosclerosis, 2016-09, Vol.252, p.e237-e238 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteinsPownall, Henry J ; Brauchi, Danièle ; Kilinç, Cumhur ; Osmundsen, Karin ; Pao, Quein ; Payton-Ross, Charlotte ; Gotto, Antonio M ; Ballantyne, Christie MAtherosclerosis, 1999-04, Vol.143 (2), p.285-297 [Periódico revisado por pares]Amsterdam: Elsevier Ireland LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Bococizumab (rn316/pf-04950615), a monoclonal antibody against pcsk9 in statin-treated hypercholesterolemic subjects: Results from a randomized, placebo-controlled, dose-ranging study (nct: 01592240)Ballantyne, C ; Neutel, J ; Cropp, A ; Duggan, W ; Wang, E ; Plowchalk, D ; Sweeney, K ; Kaila, N ; Vincent, J ; Bays, HAtherosclerosis, 2014-08, Vol.235 (2), p.e75-e76 [Periódico revisado por pares]Elsevier Ireland LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Small Dense Ldl-Cholesterol (Sdldl-C) As A Risk Enhancer Of Atherosclerotic Cardiovascular Disease (Ascvd): The Atherosclerosis Risk In Communities (Aric) StudyHoogeveen, R. ; Sun, W. ; Ballantyne, C.Atherosclerosis, 2019-08, Vol.287, p.e277-e278 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Efficacy and safety of the oral PCSK9 macrocyclic peptide inhibitor MK-0616: A phase 2B randomized controlled trialBallantyne, C. ; Banka, P. ; Mendez, G. ; Garcia, R. ; Rosenstock, J. ; Rodgers, A. ; Mendizabal, G. ; Mitchel, Y. ; Catapano, A.Atherosclerosis, 2023-08, Vol.379, p.S21 [Periódico revisado por pares]Texto completo disponível |
8 |
Material Type: Artigo
|
![]() |
ARO-ANG3, an investigational RNAI therapeutic, decreases serum LDL-cholesterol, apolipoprotein B, and angiopoietin-like protein 3 in patients with homozygous familial hypercholesterolaemiaRaal, F. ; Bergeron, J. ; Watts, G. ; Gaudet, D. ; Sullivan, D. ; Turner, T. ; Hegele, R. ; Ballantyne, C. ; Knowles, J. ; Goldberg, I. ; Fu, R. ; Alagarsamy, S. ; Hamilton, J. ; Rosenson, R.Atherosclerosis, 2023-08, Vol.379, p.S43-S44 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized studyBallantyne, Christie M ; Hoogeveen, Ron C ; Raya, Joe L ; Cain, Valerie A ; Palmer, Mike K ; Karlson, Björn WAtherosclerosis, 2014-01, Vol.232 (1), p.86-93 [Periódico revisado por pares]Ireland: Elsevier Ireland LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Efficacy and Safety of Bempedoic Acid + Ezetimibe Fixed-Dose Combination in Patients at High CVD Risk and with Elevated LDL-C Receiving Maximally Tolerated Statin TherapyBallantyne, C. ; Laufs, U. ; Ray, K.K. ; Leiter, L.A. ; Bays, H.E. ; Goldberg, A.C. ; Stroes, E.S.G. ; MacDougall, D. ; Zhao, X. ; Catapano, A.L.Atherosclerosis, 2019-08, Vol.287, p.e7-e8 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |